Corbus Pharmaceuticals Holdings, Inc. · DUS:3371
Corbus Pharmaceuticals Holdings, Inc. shareholders
As of Sep 30, 2026, 114 institutions reported holding Corbus Pharmaceuticals Holdings, Inc., 85.5% of its shares. Largest: Cormorant Asset Management, LP, Ra Capital Management, L.P. and BlackRock. New holders, exits, insiders and big stakes, each with its filing.
Shareholders
Institutions
| Holder | Shares | Of the company | Value | As of |
|---|---|---|---|---|
| Cormorant Asset Management, LP | 2.34M | 11.4% | US$16M | Sep 30, 2026 |
| Ra Capital Management, L.P. | 1.91M | 9.3% | US$13.1M | Sep 30, 2026 |
| BlackRock | 1.75M | 8.5% | US$11.9M | Sep 30, 2026 |
| Mpm Bioimpact LLC | 1.67M | 8.1% | US$11.4M | Sep 30, 2026 |
| Orbimed Advisors LLC | 1.67M | 8.1% | US$11.4M | Sep 30, 2026 |
| Vanguard | 995K | 4.8% | US$6.79M | Sep 30, 2026 |
| Jones Hill Capital LP | 886K | 4.3% | US$6.05M | Sep 30, 2026 |
| Sio Capital Management, LLC | 766K | 3.7% | US$5.23M | Sep 30, 2026 |
| Caption Management, LLC | 475K | 2.3% | US$3.24M | Sep 30, 2026 |
| Geode Capital | 451K | 2.2% | US$3.07M | Sep 30, 2026 |
| AQR Capital Management LLC | 335K | 1.6% | US$2.29M | Sep 30, 2026 |
| Marshall Wace, LLP | 308K | 1.5% | US$2.1M | Sep 30, 2026 |
| Susquehanna | 300K | 1.5% | US$2.04M | Sep 30, 2026 |
| State Street | 262K | 1.3% | US$1.78M | Sep 30, 2026 |
| Dimensional | 210K | 1.0% | US$1.43M | Sep 30, 2026 |
| ADAR1 Capital Management, LLC | 195K | 0.95% | US$1.33M | Sep 30, 2026 |
| Exome Asset Management LLC | 191K | 0.93% | US$1.3M | Sep 30, 2026 |
| MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. | 181K | 0.88% | US$1.24M | Sep 30, 2026 |
| Prosight Management, LP | 168K | 0.82% | US$1.15M | Sep 30, 2026 |
| UBS | 139K | 0.68% | US$950K | Sep 30, 2026 |
| Goldman Sachs | 128K | 0.62% | US$873K | Sep 30, 2026 |
| Northern Trust | 127K | 0.62% | US$868K | Sep 30, 2026 |
| Fidelity | 127K | 0.62% | US$866K | Sep 30, 2026 |
| Nuveen | 116K | 0.56% | US$788K | Sep 30, 2026 |
| Stonepine Capital Management, LLC | 95,000 | 0.46% | US$648K | Sep 30, 2026 |
| Renaissance Technologies | 94,900 | 0.46% | US$647K | Sep 30, 2026 |
| Morgan Stanley | 93,085 | 0.45% | US$635K | Sep 30, 2026 |
| Point72 Asset Management, L.P. | 89,312 | 0.43% | US$609K | Sep 30, 2026 |
| HSBC | 87,173 | 0.42% | US$592K | Sep 30, 2026 |
| Advisory Services Network, LLC | 85,351 | 0.41% | US$582K | Sep 30, 2026 |
| DAFNA Capital Management LLC | 83,248 | 0.40% | US$568K | Sep 30, 2026 |
| Millennium | 81,269 | 0.39% | US$554K | Sep 30, 2026 |
| XTX Topco Ltd | 79,952 | 0.39% | US$545K | Sep 30, 2026 |
| BNP Paribas | 78,274 | 0.38% | US$534K | Sep 30, 2026 |
| Doliver Advisors, LP | 75,975 | 0.37% | US$518K | Sep 30, 2026 |
| Walleye Capital LLC | 75,795 | 0.37% | US$517K | Sep 30, 2026 |
| Schwab | 64,831 | 0.31% | US$442K | Sep 30, 2026 |
| Rangeley Capital, LLC | 61,400 | 0.30% | US$419K | Sep 30, 2026 |
| Verdad Advisers, LP | 60,566 | 0.29% | US$413K | Sep 30, 2026 |
| Simplex Trading, LLC | 47,857 | 0.23% | US$326K | Sep 30, 2026 |
| BNY | 45,282 | 0.22% | US$309K | Sep 30, 2026 |
| D. E. Shaw & Co., Inc. | 39,502 | 0.19% | US$269K | Sep 30, 2026 |
| Driehaus Capital Management LLC | 38,977 | 0.19% | US$266K | Sep 30, 2026 |
| Panagora Asset Management Inc | 35,505 | 0.17% | US$242K | Sep 30, 2026 |
| LMR Partners LLP | 35,500 | 0.17% | US$242K | Sep 30, 2026 |
| Barclays | 35,144 | 0.17% | US$240K | Sep 30, 2026 |
| Cantor Fitzgerald, L. P. | 30,000 | 0.15% | US$205K | Sep 30, 2026 |
| Velan Capital Investment Management LP | 30,000 | 0.15% | US$205K | Sep 30, 2026 |
| Bank of America | 29,641 | 0.14% | US$202K | Sep 30, 2026 |
| Sectoral Asset Management Inc | 28,000 | 0.14% | US$191K | Sep 30, 2026 |
This page holds 50 of 114 holders.
Funds
This page holds 50 of 81 holders.
Big stakes
| Stake | Stake | Shares | Date | Filing |
|---|---|---|---|---|
| Ra Capital Management, L.P. | 9.90% | 1.91M | Sep 23, 2026 | Schedule 13G |
| Mpm Bioimpact LLC | 8.60% | 1.67M | Sep 30, 2026 | Schedule 13G |
| Cormorant Asset Management, LP | 7.76% | 1.5M | Oct 31, 2026 | Schedule 13G |
| BlackRock, Inc. | 5.90% | 1.09M | Jun 30, 2026 | Schedule 13G |
| Orbimed Advisors LLC | 5.90% | 718K | Dec 31, 2024 | Schedule 13G |